Department of Cardiovascular and Endocrine-Metabolic Diseases and Aging, Italian National Institute of Health, Rome 00161, Italy.
Reference Center for Behavioral Sciences and Mental Health, Italian National Institute of Health, Rome 00161, Italy.
J Clin Endocrinol Metab. 2024 Jan 18;109(2):e495-e507. doi: 10.1210/clinem/dgad593.
In 2005, a nationwide program of iodine prophylaxis on a voluntary basis was implemented in Italy by law. However, recent data on iodine status are lacking.
The aim of this study was to evaluate efficiency, effectiveness, and possible adverse effects (increased occurrence of thyroid autoimmunity and hyperthyroidism) of the Italian iodine prophylaxis program.
From 2015 to 2019, a nationwide survey was performed. The use of iodized salt was evaluated in a sample of 164 593 adults and in 998 school canteens. A sample of 4233 schoolchildren (aged 11-13 years) was recruited to assess urinary iodine concentration, prevalence of goiter, and thyroid hypoechogenicity on ultrasound, with the latter being an indirect indicator of thyroid autoimmunity. Neonatal TSH values of 197 677 infants screened in regions representative of Northern, Central, and Southern Italy were analyzed to investigate the percentage of TSH values >5.0 mIU/L. Data on methimazole prescriptions were analyzed as indirect indicators of new cases of hyperthyroidism.
The prevalence of the use of iodized salt was 71.5% in adult population and 78% in school canteens. A median urinary iodine concentration of 124 μg/L, a prevalence of goiter of 2.2%, and a prevalence of thyroid hypoechogenicity of 5.7% were observed in schoolchildren. The percentage of neonatal TSH values >5.0 mIU/L resulted still higher (5.1%) than the World Health Organization threshold of 3.0%, whereas the prescriptions of methimazole showed a reduction of 13.5%.
Fifteen years of iodine prophylaxis have led to iodine sufficiency in Italy, although there still is concern about iodine nutritional status during pregnancy.
2005 年,意大利通过法律在全国范围内实施了一项基于自愿原则的碘预防计划。然而,目前缺乏有关碘状况的最新数据。
本研究旨在评估意大利碘预防计划的效率、效果和可能的不良反应(甲状腺自身免疫和甲状腺功能亢进症的发生率增加)。
2015 年至 2019 年期间进行了一项全国性调查。评估了 164593 名成年人和 998 个学校食堂中碘盐的使用情况。招募了 4233 名 11-13 岁的学童,以评估尿碘浓度、甲状腺肿患病率和超声检查的甲状腺低回声,后者是甲状腺自身免疫的间接指标。分析了在代表意大利北部、中部和南部地区筛选的 197677 名婴儿的新生儿 TSH 值,以调查 TSH 值>5.0 mIU/L 的百分比。分析了甲巯咪唑处方数据,作为新发生甲状腺功能亢进症的间接指标。
成年人和学校食堂中碘盐使用率分别为 71.5%和 78%。学童的尿碘中位数为 124μg/L,甲状腺肿患病率为 2.2%,甲状腺低回声患病率为 5.7%。新生儿 TSH 值>5.0 mIU/L 的百分比仍然高于世界卫生组织的 3.0%阈值(5.1%),而甲巯咪唑的处方则减少了 13.5%。
碘预防计划实施 15 年后,意大利碘营养状况已达到充足水平,但仍需关注孕期碘营养状况。